Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus

被引:22
作者
Yoshida, S. [1 ]
Maeda, M. [1 ]
Kaku, S. [1 ]
Ikeya, H. [1 ]
Yamada, K. [1 ]
Nakaike, S. [1 ]
机构
[1] Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Neuropsychopharmacol, Kanazawa, Ishikawa 920, Japan
关键词
stress; tau phosphorylation; GSK-3; beta; lithium;
D O I
10.1007/s00702-006-0528-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It has been pointed out that hyperphosphorylation of microtubule-associated protein tau caused by stress might participate in the early stages of Alzheimer's disease pathogenesis. In the present study, we investigated the effects of cold water stress (CWS) on tau phosphorylation in the mouse hippocampus and the effects of GSK-3 beta inhibitor, LiCl, on CWS-induced changes in tau phosphorylation levels by immunoblot analyses. CWS exposure caused an increase in tau phosphorylation at the Tau-1 (Ser199/202), AT8 (Ser202/Thr205) and Ser396 sites. CWS-induced changes in tau phosphorylation at the Ser199/202 and Ser396, but not at Ser202/Thr205, were significantly attenuated by LiCl pretreatment. Total tau levels also showed a decided tendency to increase after CWS, which tendency was also countered by LiCl. Finally, we showed that CWS increased the active form of GSK-3 beta that was phosphorylated at Tyr216. These results suggest that a CWS-induced increase in phosphorylated tau in the hippocampus is mediated, at least partly, by the activation of GSK-3 beta.
引用
收藏
页码:1803 / 1814
页数:12
相关论文
共 33 条
  • [1] A cell biological perspective on Alzheimer's disease
    Annaert, W
    De Strooper, B
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2002, 18 : 25 - 51
  • [2] Lithium augmentation in treatment-resistant-depression:: Meta-analysis of placebo-controlled studies
    Bauer, M
    Döpfmer, S
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) : 427 - 434
  • [3] The occurrence of depressive symptoms in the preclinical phase of AD -: A population-based study
    Berger, AK
    Fratiglioni, L
    Forsell, Y
    Winblad, B
    Bäckman, L
    [J]. NEUROLOGY, 1999, 53 (09) : 1998 - 2002
  • [4] Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231
    Buerger, K
    Zinkowski, R
    Teipel, SJ
    Arai, H
    DeBernardis, J
    Kerkman, D
    McCulloch, C
    Padberg, F
    Faltraco, F
    Goernitz, A
    Tapiola, T
    Rapoport, SI
    Pirttilä, T
    Möller, HJ
    Hampel, H
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02) : 376 - 379
  • [5] BUSIGLIO J, 1995, NEURON, V14, P879
  • [6] The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
    Chen, G
    Huang, LD
    Jiang, YM
    Manji, HK
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) : 1327 - 1330
  • [7] Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
    De Sarno, P
    Li, XH
    Jope, RS
    [J]. NEUROPHARMACOLOGY, 2002, 43 (07) : 1158 - 1164
  • [8] Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress
    Feng, Q
    Cheng, B
    Yang, R
    Sun, FY
    Zhu, CQ
    [J]. NEUROSCIENCE LETTERS, 2005, 388 (01) : 13 - 16
  • [9] Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain - Implications for neurofibrillary degeneration in Alzheimer's disease
    Gong, CX
    Lidsky, T
    Wegiel, J
    Zuck, L
    Grundke-Iqbal, I
    Iqbal, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) : 5535 - 5544
  • [10] AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
    Gould, TD
    Einat, H
    Bhat, R
    Manji, HK
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (04) : 387 - 390